TATVA CHIN PHARM CHEM LTD Fair Value
TATVA · Chemicals · Current price ₹1,579
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹244 | 6% ROE fading to 13% over ~10 yrs, on ₹334 book |
| Relative P/E | ₹1,062 | EPS × 59.1 peer-median P/E |
| Graham floor | ₹368 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | ₹1,443 | Street consensus 12-month target price |
Is TATVA CHIN PHARM CHEM LTD undervalued?
DocStoX estimates the fair value of TATVA CHIN PHARM CHEM LTD at ₹643 per share, versus the current market price of ₹1,579. That puts the stock about -59.3% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹244), Relative P/E (₹1,062), Graham floor (₹368), Analyst target (₹1,443). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹244 (bear) to ₹643 (base) to ₹1,443 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on TATVA CHIN PHARM CHEM LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.